The Glycobiology of Cancer Symposium (day 2) - In-Person Session
01:00 PM-05:15 PM(EST)
Virtual
NIH Videocast,
Bethesda, MD - 20892
Max.Capacity: 1000 No Participants
Agenda:
Chair, Dr. Neeraja Sathyamoorthy, Program Director, NCI
1:00p.m., Dr. Mauricio Reginato, Drexel University
O-GlcNAcylation: Linking Signaling and Metabolism in Cancer
1:30p.m., Dr. Virginia Shapiro, Mayo Rochester
ST8Sia6 Promotes Tumor Growth in Mice by Inhibiting Immune Responses
2:00p.m, Dr. Anita Hjelmeland, University of Alabama Birmingham
A Protumorigenic Role for ST6Gal1-Mediated Sialylation in Brain Tumor Initiating Cells
2:30p.m., Dr. Thomas Clausen, University of California San Diego
Binding of Malarial VAR2CSA to Oncofetal Chondroitin Sulfate Depends on Sulfation and Ligand Accessibility
3:00p.m., Break
Session IV. Glycoproteomics & Informatics
Chair, Dr. Karl Krueger, Program Director, NCI
3:15p.m., Dr. Richard Drake, Medical University of South Carolina
Integrated Workflows for Carbohydrate Antigen Immunohistochemistry, N-glycan Imaging Mass Spectrometry and Targeted Glycoproteomics on the Same Tumor Tissue Slide
3:45p.m., Dr. Stacy Malaker, Yale University
Revealing the Cancer-Associated Mucinome
4:00p.m., Dr. Hui Zhang, Johns Hopkins School of Medicine
Characterization of Human Cancers by Glycoproteomics
4:30p.m., Dr. Raja Mazumder, George Washington University
Exploring Cancer Mutations and its Effect on Glycosylation Sites Using GlyGen Supersearch
4:45p.m., Dr. Lingjun Li, University of Wisconsin
Development and Application of Chemical Tags for Quantitative Glycomics and Glycoproteomics
5:15p.m., Adjourn